Sofie Jacobs

9PUBLICATIONS
119CO-AUTHORS
Biomolecular modelling and designInnate immunityMedical virologyDevelopment studies not elsewhere classifiedAnimal cell and molecular biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 27, 2025
A small-molecule SARS-CoV-2 inhibitor targeting the membrane protein.

Ellen Van Damme, Pravien Abeywickrema, Yanting Yin

|Oct 05, 2021
An affinity-enhanced, broadly neutralizing heavy chain-only antibody protects against SARS-CoV-2 infection in animal models.

Bert Schepens, Loes van Schie, Wim Nerinckx

|Apr 30, 2021
Favipiravir Does Not Inhibit Chikungunya Virus Replication in Mosquito Cells and <i>Aedes aegypti</i> Mosquitoes.

Sofie Jacobs, Lanjiao Wang, Ana Lucia Rosales Rosas

|Feb 11, 2021
Recent African strains of Zika virus display higher transmissibility and fetal pathogenicity than Asian strains.

Fabien Aubry, Sofie Jacobs, Maïlis Darmuzey

|Nov 18, 2020
STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters.

Robbert Boudewijns, Hendrik Jan Thibaut, Suzanne J F Kaptein

|Oct 10, 2020
Favipiravir at high doses has potent antiviral activity in SARS-CoV-2-infected hamsters, whereas hydroxychloroquine lacks activity.

Suzanne J F Kaptein, Sofie Jacobs, Lana Langendries

Pageof 2